[Retracted] Effects of Deep Hyperthermia Combined with Intraperitoneal Chemotherapy on Liver-Kidney Function, Immune Function, and Long-Term Survival in Patients with Abdominal Metastases

Table 3

Survival analysis of the two groups of patients.

Group	Median survival (months)	OS (%)	mPFS (months)
Control group (n = 41)	20.21	5/41 (12.20)	6.35
Observation group (n = 42)	28.93	11/42 (26.19)	10.47
Log rank χ^2	—	5.776	—
	—	0.016	—